Life Sciences Archive » August, 2025

Life Sciences - August, 2025

124 articles

• Judge Says Patents In $50M Amgen Jury Loss Unenforceable
• OptumRx Flags Email Accidentally Sent To Opioid MDL Parties
• Armistice Capital Beats Derivative Suit In Chancery
• Amid IP Fight, Apple Restores Watch's Blood Oxygen Monitor
• Conn. Lab To Pay $1.25M In False Claims Settlement
• USPTO's AI Tool Redefines Design Patent Landscape
• Class Actions At The Circuit Courts: August Lessons
• AGs' Dermatology Price-Fixing Case Not A Copy, Judge Says
• Hiking Makes Me A Better Lawyer
• Eli Lilly To Put $1.3B Into Obesity-Focused Medicine Biz
• What Attys Want To Know About Lutnick's Harvard IP Threat
• Whoop's Health Tracker Accused Of Sharing Users' Data
• David Protein Tees Up Bid To Toss Ingredient Antitrust Suit
• Labcorp Wins ERISA Trial As Judge Cites Stronger Witnesses
• Wash. Court Allows Vacated Conviction DNA To Prove Rape
• Cassava Investors Get Class Certified In Alzheimer's Drug Suit
• Texas Woman Says Marine Laced Her Drink With Abortion Pills
• Suit Claims UPPAbaby Car Seats Asphyxiate Infants
• What US-India Trade Deal Will Mean For Indian Pharma
• Time For Full Disclosure Of Third-Party Funding In MDLs
• Fed. Circ. Throws Out $4.7M Verdict In DNA Patent Suit
• NC Businessman Nabs Early Exit From Investment Fraud Suit
• Law School's Missed Lessons: Negotiation Skills
• Judge, Terumo Attorney Spar Over 'Final Judgment' Case
• 9th Circ. Reverses Trade Secrets Striking In Biotech Suit
• Texas Says Eli Lilly Offered Nursing Services As Kickbacks
• Worker's Flu Shot Ruling Goes Too Far, 5th Circ. Dissent Says
• Biogen Says It Owes Nothing After $122M IP Royalties Mistrial
• AstraZeneca, Stockholders Far Apart In Merger Damages Tally
• Conflicting Developments In Homelessness Legal Landscape
• Bayer Bets $1.3B On Kumquat Cancer Drug Candidate
• AG Watch: Texas Embraces The MAHA Movement
• FTC Skeptical Of 'Partial' Sale For GTCR Merger Fix
• Roche Settles Trade Secrets Suit With Stanford And Profs
• Bar Exam Reform Must Expand Beyond A Single Updated Test
• The Patent Eligibility Eras Tour: 11 Years Of Post-Alice Tumult
• Abbott Shakes Suit Over Meta, Google Data Sharing For Now
• GTCR Says Sale, Market Nix FTC Med Tech Merger Concerns
• Aetna, CVS Want Lab's $21M Payment Suit Tossed For Good
• Judge Rules NYC Can Enforce Kava Cafe Shutdowns
• Apple Prevails In Heartbeat Patent Suit On Standing, Invalidity
• Location Data And Online Tracking Trends To Watch
• Judge OKs Becton Dickinson's $9M Investor Settlement
• SEC Says Biotech Investor Traded On Inside Info About Deal
• A Simple Way Courts Can Help Attys Avoid AI Hallucinations
• DOJ Consumer Branch's End Leaves FDA Litigation Questions
• Trump Admin Threatens To Take Harvard's Patents
• MSN Calls On Full Fed. Circ. To Rethink Double Patenting Rule
• How Patent Attys Can Limit 'Skinny Label' Risks In Ads
• GlaxoSmithKline Will Get $500M In CureVac-Pfizer Patent Deal
• FTC Maintains Support For Right-To-Repair In Med Robot Case
• Trump EO Requires Appointee Oversight Of US Grantmaking
• NJ Nonprofit Says Foundation Trying To Take Over Business
• Pa. Pharmacy To Pay $825K To Resolve False Claims Case
• Iowa PBM Law Challengers Seek Wider Block At 8th Circ.
• Attys Seek Final OK Of $100M Walgreens Rx Cost Settlement
• Stewart Rejects 8 IPR Petitions While Overriding May Denial
• The Evolving Legal Landscape For THC-Infused Beverages
• Medical Tech Startup Heartflow's Upsized IPO Raises $317M
• Taxation With Representation: Latham, Alston & Bird, Orrick
• UK Litigation Roundup: Here's What You Missed In London
• HHS Wins Another Round In Medicare Drug Negotiation Battle
• BioNTech's Acquisition Of CureVac Ends COVID Vax Case
• BioPharma Co.'s $15M Deal Over Ruined J&J Vaccines OK'd
• Michigan AG Fights Bid To Pause PBM Price-Fixing Suit
• Ex-Worker Sues Firm For Bias After Work On CDC Contract
• Novartis Faces $291M Trade Secrets Suit From Hedge Fund
• Anthem Seeks Exit From Lab's $3.8M Insurance Suit
• 2nd Circ. Axes Challenge To Medicare Drug Price Negotiations
• Rising Star: Goodwin's Laura Umbrecht Gulick
• Investors Back Cancer Ultrasound Tech Firm At $2.25B Value
• Fed. Circ. Affirms PTAB Ax Of Bone Fusion Device Patents
• NC Biz Court Bulletin: Divorce Dust-Ups And Judicial Rebukes
• Creating Botanical Art Makes Me A Better Lawyer
• 6th Circ. Rips 'Stalking Horse' Ploy In Drug Negotiation Suit
• Ga. Judges Weigh Birth Defect Ruling in Sterigenics Case
• Masimo Drops Founder Joe Kiani From 'Empty Voting' Suit
• Indivior Beats Investor Suit Over Opioid Drug Sales Forecasts
• Insulin Collusion Needn't Be 'Clever' To Exist, 2nd Circ. Says
• State AGs Want Final OK For $39M Apotex Price-Fixing Deal
• Judge OKs Addition Of Kenvue, Janssen To J&J Talc MDL
• Rising Star: Quinn Emanuel's Frank Calvosa
• FTC Challenges $945M Heart Valve Deal
• 2nd Circ. Backs J&J Spinoff In 'Rapid Release' Label Suit
• Novo Nordisk Lodges Suits Over 'Knockoff' Semaglutide Meds
• OptumRx Urges Panel To DQ Motley Rice In LA Opioid Suit
• Key Opioid Theory Actually Irrelevant, Drug Cos. Tell 4th Circ.
• Ex-USPTO Heads, Judges Oppose Anti-Patent Thicket Bill
• Stewart Won't Reconsider Her 1st Settled Expectations Denial
• Lead Kicked From Pharma Investor Case Over Rogue Emails
• A Free Exercise 'Blueprint' In Colo. Abortion Reversal Order
• The Legal Education Status Quo Is No Longer Tenable
• Rising Star: Baker McKenzie's Piotr Korzynski
• Teva Settles Claims Over Delayed Generic Asthma Inhalers
• 2nd Circ. Reinforces Consensus On Vacating Foreign Awards
• Fla. Biz Won't Sell Knockoff Weight Loss Drugs After AG Deal
• Pharma Startup Claims Lupin Stole Inhaler Trade Secrets
• Gibson Dunn, Wachtell Advise On $1.5B Vision Implant Deal
• Trump's Sons Back 'New America' SPAC's $300M IPO Filing
• MOVEit Data Breach MDL Advances With Slimmed Frame
• GTCR Says Buyer In Place For Potential FTC Divestiture Deal
• Feds Get 2nd Crack At Regeneron FCA Case After Key Ruling
• Chemical Group Says Fluoride Judge Got It Wrong
• Investors Say Novo Nordisk Misled Them Over Drug Demand
• Moderna Seeks To Be Cleared In $5B COVID Vax Patent Case
• Rising Star: Keker's Bailey Heaps
• Barnes & Thornburg Adds Leader Of FDA Practices At 2 Firms
• Healthcare Investor Clinches $1.86B For 5th Credit Fund
• E-Discovery Quarterly: Rulings On Relevance Redactions
• Ex-FDA Chief Of Staff Joins Hogan Lovells' Pharma Team
• Meta Illegally Recorded Flo Users' Data, Calif. Jury Finds
• Wheeling & Appealing: Midyear Highlights For Every Circuit
• IP Owners Largely Win In Stewart's Newest Discretion Orders
• USPTO Tightens Rules On Patent Challengers' Arguments
• AGs Sue Trump Over 'Onslaught Of Pressure' On Trans Care
• En Banc 9th Circ. Backs LA Schools In Vax Mandate Fight
• States Urge High Court To Keep NIH Grant Funds Flowing
• Monthly Merger Review Snapshot
• How DOJ's New Data Security Rules Leave HIPAA In The Dust
• Section 1983 Has Promise After End Of Nationwide Injunctions
• OptumRx Moves To DQ Motley Rice In Utah Opioid Case
• Trump's 2nd Term Puts Merger Remedies Back On The Table
• J&J Unit's Catheter Rival Scores Injunction After $442M Win
• Patent Ambiguity Persists After Justices Nix Eligibility Appeal